DavidAlanBondMD

PubMed

• Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
  Adam S Kittai, David Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carr...> ;Journal of Clinical Oncology. 2024 Mar 29
• 9 citations
  Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
  David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C Godby, David A Bond, Graham T Wehmeyer, Jason Romancik, Behzad Amoozga...> ;Blood. 2023 Dec 28
• Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
  Gerson, J., Handorf, E., Villa, D., Gerrie, A., Chapani, P., Li, S., Medeiros, L., Wang, M., Cohen, J., Churnetski, M., Hill, B., Sawalha, Y., Hernandez-Ilizaliturri, ...> ;Blood Advances. 2023 Dec 26
• 4 citations
  High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
  Zayac, A., Landsburg, D., Hughes, M., Bock, A., Nowakowski, G., Ayers, E., Girton, M., Hu, M., Beckman, A., Li, S., Medeiros, L., Chang, J., Stepanovic, A., Kurt, H., ...> ;Blood Advances. 2023 Nov 14
• 2 citations
  Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.
  Tycel J Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria Nachar, Ryan A Wilcox, Shannon A Carty, Yasmin...> ;Blood Advances. 2023 Aug 22
• 2 citations
  Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma.
  Diego Villa, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J Buege, Anita Kumar, David A Bond, Jonas Paludo, Matthew J Maurer, Gita Thanarajasing...> ;Blood Advances. 2023 Aug 22
• 4 citations
  Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
  Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie S Grover, Stephanie Mathews, Made...> ;Blood Advances. 2023 Jun 13
• 8 citations
  Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
  Major, A., Major, A., Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, ...> ;American Journal of Hematology. 2023 Jun 1
• TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.
  Max J Gordon, David A Bond, Adam S Kittai, Neda Amirmokhtari, Abigail Steinbrunner, Allison Huffman, Victor Orellana-Noia, Geoffrey Shouse, Jonathon B Cohen, Tycel Phi...> ;Haematologica. 2023 Nov 1
• Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy.
  Kaitlin Annunzio, Michael Cackovic, David Bond, Yazeed Sawalha, Timothy J Voorhees, Walter Hanel, Lapo Alinari, Robert Baiocchi, John Reneau, Jonathan Brammer, Kami Ma...> ;Blood Advances. 2023 May 23
• 2 citations
  EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
  Agrawal, P., David, K., Chen, Z., Sundaram, S., Kim, S., Vaca, R., Lin, Y., Singer, S., Malecek, M., Carter, J., Zayac, A., Kim, M., Reddy, N., Ney, D., Habib, A., Str...> ;Leukemia & Lymphoma. 2023 May 1
• 4 citations
  A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
  Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, ...> ;Cancers. 2023 Feb 24
• Development of recalcitrant cutaneous eruptions in patients with relapsed/refractory Hodgkin's lymphoma undergoing treatment with camidanlumab tesirine.
  Sonia Himed, Catherine Chung, Brittany Dulmage, Samantha Jaglowski, David Bond, Kami Maddocks, Benjamin H Kaffenberger> ;Journal of the European Academy of Dermatology and Venereology. 2023 Jul 1
• Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.
  Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, Rui Li, Ying Huang, Abdullah Khan, David Bond, Yazeed Sawalha, John Reneau, Lapo Alinari, Robert Baiocchi, Beth...> ;Cancer Medicine. 2023 Apr 1
• Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia.
  Ansel Nalin, Qiuhong Zhao, Timothy Voorhees, David Bond, Yazeed Sawalha, Walter Hanel, Audrey Sigmund, Kaitlin Annunzio, Lapo Alinari, Robert Baiocchi, Kami Maddocks, ...> ;Frontiers in Oncology. 2023 Jan 1
• Evidence-Based Minireview: When should autologous transplant or cellular therapy be considered for follicular lymphoma?
  David A Bond, Ajay K Gopal> ;Hematology. American Society of Hematology. Education Program. 2022 Dec 9
• 6 citations
  Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
  Adam S Kittai, Ying Huang, Kyle A Beckwith, Seema A Bhat, David A Bond, John C Byrd, Daniel Goldstein, Michael R Grever, Cecelia Miller, Kerry A Rogers, Jennifer A Woy...> ;American Journal of Hematology. 2023 Jan 1
• 6 citations
  Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
  Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, Seongho Kim, Krish Patel, Nancy L Bartlett, Mary-Kate Malecek, Marcus P Watkins, Kami J Maddocks, David A Bond,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Jul 1
• 3 citations
  Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma.
  Audrey M Sigmund, Nathan Denlinger, Ying Huang, David Bond, Timothy Voorhees, Amneet Bajwa, Patrick Elder, Jonathan E Brammer, Ayman Saad, Sam Penza, Sumithira Vasu, M...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• 21 citations
  CAR T-cell therapy for B-cell lymphoma.
  Nathan Denlinger, David Bond, Samantha Jaglowski> ;Current Problems in Cancer. 2022 Feb 1
• 2 citations
  Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methot...
  Megan Fleming, Ying Huang, Emily Dotson, David A Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan Brammer, Beth Christian, Robert A Baiocchi, Kami Maddo...> ;Therapeutic Advances in Hematology. 2022 Jan 1
• 4 citations
  Feasibility of High-dose Methotrexate Administered on Day 1 of (R)CHOP in aggressive non-Hodgkin Lymphomas.
  Megan K Fleming, Ying Huang, Emily Dotson, David A. Bond, John C. Reneau, Narendranath Epperla, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert A. Baiocchi, ...> ;Blood Advances. 2021 Nov 17
• 21 citations
  Early Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.
  David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bha...> ;Blood Advances. 2021 Sep 13
• 11 citations
  Multi-Center Analysis of Practice Patterns and Outcomes of Younger and Older Patients with Mantle Cell Lymphoma in the Rituximab Era.
  Reem Karmali, Jeffrey M. Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C. Churnetski, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta...> ;American Journal of Hematology. 2021 Jul 29
• 24 citations
  The impact of increasing karyotypic complexity and evolution on survival in CLL patients treated with ibrutinib.
  Adam Kittai, Cecelia R. Miller, Daniel Goldstein, Ying Huang, Lynne V. Abruzzo, Kyle A. Beckwith, Seema A. Bhat, David A. Bond, Michael R. Grever, Nyla A. Heerema, Ker...> ;Blood. 2021 Jul 27
• Join now to see all

Abstracts/Posters

• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
  David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Second cancer incidence in CLL patients receiving BTK inhibitors. 
  2019 ASCO Annual Meeting - 6/1/2019